Trastuzumab Deruxtecan Effective For HR-Positive, HER2-Low Breast Cancer Treatment After Endocrine Therapy Read More » June 14, 2024
Liver Transplantation Superior to Chemotherapy Alone for CRC Liver Metastases Read More » June 14, 2024
Inavolisib Plus Palbociclib/Fulvestrant Bolsters PFS in HR+/HER2–, PIK3CA-Mutant Breast Cancer Read More » June 14, 2024
Trastuzumab Deruxtecan Effective For HR-Positive, HER2-Low Breast Cancer Treatment After Endocrine Therapy Read More » June 14, 2024
